Could LifeVantage Corp (LFVN) Rise Even More? The Stock Had Another Big Increase Today

September 17, 2017 - By Adrian Erickson

The stock of LifeVantage Corp (NASDAQ:LFVN) is a huge mover today! The stock increased 4.90% or $0.2 on September 15, reaching $4.28. About 68,309 shares traded. LifeVantage Corp (NASDAQ:LFVN) has declined 64.65% since September 17, 2016 and is downtrending. It has underperformed by 81.35% the S&P500.
The move comes after 6 months positive chart setup for the $60.90M company. It was reported on Sep, 17 by Barchart.com. We have $4.45 PT which if reached, will make NASDAQ:LFVN worth $2.44M more.

More notable recent LifeVantage Corp (NASDAQ:LFVN) news were published by: Prnewswire.com which released: “Ryan & Maniskas, LLP Announces Class Action Lawsuit Against LifeVantage …” on March 21, 2016, also Forbes.com with their article: “The Best Performing Company In Every State, Ranked By Return” published on June 25, 2016, Globenewswire.com published: “Lawsuit for Investors in LifeVantage Corp (LFVN) shares announced by …” on October 26, 2016. More interesting news about LifeVantage Corp (NASDAQ:LFVN) were released by: Globenewswire.com and their article: “LifeVantage Corp. Receives NASDAQ Letter Related to Delay in Filing Form 10-K” published on September 30, 2016 as well as Quotes.Wsj.com‘s news article titled: “Lifevantage Corp.” with publication date: July 17, 2011.

LifeVantage Corporation is a science network marketing company. The company has market cap of $60.90 million. The Firm focuses on helping people achieve their health, wellness and financial independence goals. It has a 38.26 P/E ratio. The Firm provides products and a financially rewarding direct sales business opportunity to clients and independent distributors seeking a healthy lifestyle and financial freedom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: